Cart
sales@molnova.com
Dodecylphosphocholine
CAS No. 29557-51-5
Dodecylphosphocholine( DPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC )
Catalog No. M24215 CAS No. 29557-51-5
Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDodecylphosphocholine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
-
DescriptionDodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
-
In Vitro——
-
In Vivo——
-
SynonymsDPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC
-
PathwayOthers
-
TargetOther Targets
-
Recptorpancreas phospholipase A2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number29557-51-5
-
Formula Weight351.47
-
Molecular FormulaC17H38NO4P
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Goyal S, Qin H, Lim L, Song J. Insoluble protein characterization by circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR). Methods Mol Biol. 2015;1258:371-85. doi: 10.1007/978-1-4939-2205-5_21. Review. PubMed PMID: 25447876.
molnova catalog
related products
-
SAR131675 (b)
SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity (IC50: 20 nmol/L) and VEGFR-3 autophosphorylation (IC50: 45 nmol/L) in HEK cells, respectively.
-
PalMitoyl Tripeptide...
Palmitoyl tripeptide-1 has effects on the synthesis of collagen, fibronectin and hyaluronic acid in human skin fibroblasts, and can be used in the preparation of anti-aging cosmetics.
-
Emicizumab
Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
